AMERICAN JOURNAL OF SURGERY, vol.202, no.1, pp.10-15, 2011 (SCI-Expanded)
BACKGROUND: This study evaluated whether prophylactic treatment with a cefazolin could prevent infections in patients who had a surgically inserted totally implantable venous access device (TIVAD).